Clinical Trial Update: Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated safety, tolerability, and immunogenicity when FluMist and MMRV vaccines were administered concurrently to healthy children; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• FluMist (live attenuated influenza vaccine)
• ProQuad (Measles, Mumps, Rubella and Varicella live attenuated vaccine)

Snippet

Sponsor: MedImmune LLC | Conditions: Influenza | Phase 3 | Status: COMPLETED